Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients

Memon, Muhammad Ayoob; Khan, Raisa Noor; Riaz, Saman; Ain, Qurat Ul; Ahmed, Masood; Kumar, Naresh

doi:10.4103/jrms.jrms_1078_17

Cited by 21 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies directly administering MG have demonstrated a clear association with increased atherosclerosis, positioning MG as an active participant in the progression of this pathology [110]. Notably, MG has also been recognized as a predictor of intimal thickening in individuals with type 2 diabetes [111]. The modification of lipoproteins, specifically LDL and HDL, by MG further fuels the flames of atherosclerosis.…”

Section: Roles Of Mg and Glo In Cvdmentioning

confidence: 99%

Molecular Assessment of Methylglyoxal-Induced Toxicity and Therapeutic Approaches in Various Diseases: Exploring the Interplay with the Glyoxalase System

Alhujaily

2024

Life

View full text Add to dashboard Cite

This comprehensive exploration delves into the intricate interplay of methylglyoxal (MG) and glyoxalase 1 (GLO I) in various physiological and pathological contexts. The linchpin of the narrative revolves around the role of these small molecules in age-related issues, diabetes, obesity, cardiovascular diseases, and neurodegenerative disorders. Methylglyoxal, a reactive dicarbonyl metabolite, takes center stage, becoming a principal player in the development of AGEs and contributing to cell and tissue dysfunction. The dual facets of GLO I—activation and inhibition—unfold as potential therapeutic avenues. Activators, spanning synthetic drugs like candesartan to natural compounds like polyphenols and isothiocyanates, aim to restore GLO I function. These molecular enhancers showcase promising outcomes in conditions such as diabetic retinopathy, kidney disease, and beyond. On the contrary, GLO I inhibitors emerge as crucial players in cancer treatment, offering new possibilities in diseases associated with inflammation and multidrug resistance. The symphony of small molecules, from GLO I activators to inhibitors, presents a nuanced understanding of MG regulation. From natural compounds to synthetic drugs, each element contributes to a molecular orchestra, promising novel interventions and personalized approaches in the pursuit of health and wellbeing. The abstract concludes with an emphasis on the necessity of rigorous clinical trials to validate these findings and acknowledges the importance of individual variability in the complex landscape of health.

show abstract

Section: Roles Of Mg and Glo In Cvdmentioning

confidence: 99%